[Clinical comparison of dextran 40 and xantinol nicotinate in the treatment of sudden deafness caused by shock waves (author's transl)].
The therapeutic success of inner ear lesions by acute acoustic trauma was examined by two statistically comparable groups of patients. 80 patients were attended by dextran 40 and 59 by xantinol nicotinate. The amelioration of hearing and tinnitus was statistically better after treatment with dextran 40.
D003911:Dextrans / Q000627:therapeutic use*; D007758:Ear, Inner; D006317:Hearing Loss, Noise-Induced / Q000188:drug therapy*; D006801:Humans; D013806:Theophylline / Q000031:analogs & derivatives*; D013997:Time Factors; D014012:Tinnitus / Q000188:drug therapy; D014971:Xanthinol Niacinate / Q000627:therapeutic use*
D003911:Dextrans; D014971:Xanthinol Niacinate; D013806:Theophylline
Klinischer Vergleich der Monosubstanzen Dextran 40 und Xantinol-nicotinat in der Therapie des Knalltraumas.